Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

The quality of the terms of the partnership for Navidea is far more significant than just getting partnerships and announcing them. So far, the two partnerships that have been announced have been insignificant as far as the future profit for Navidea to come from them and the market made such very clear. If future partnership announcements have a similar minimal cash up front to Navidea (or even cost Navidea money up front like one partnership did) coupled with an insignificant amount of the product sale revenue staying with Navidea, partnerships will not turn the disgusting share price around. A partnership with a major pharmaceutical is likely all that will ever matter...

And all of this recent talk about the company now starting to educate doctors about Lymphoseek is beyond infuriating. Pykett, Tulip, and Larson collectively earned well over $1 million in 2012, 2013, and 2014 YET THEY ALLOWED LYMPHOSEEK SALES TO BE SO MINIMAL?

I again maintain that salary cuts for 2015 are more than called for UNTIL AND UNLESS Lymphoseek sales DRASTICALLY IMPROVE!